NEOGEN CORP

NEOGEN CORP

Neogen Corporation (NEOG) supplies testing, products and services aimed at food and animal safety. The company sells diagnostic kits, sanitising and lab equipment, veterinary instruments and related consumables to food processors, retailers and animal-health customers. With a market capitalisation around $1.28bn, Neogen operates in a specialist niche where regulatory standards, outbreak prevention and quality assurance drive demand. Growth has come from product development and selective acquisitions, giving scale in both testing technologies and consumables. Investors should note the business can be cyclical with exposure to food-industry spending and margins influenced by rawโ€‘material and integration costs. This summary is general educational information, not personalised advice โ€” stocks can fall as well as rise, and suitability depends on your financial situation and risk tolerance.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts suggest buying Neogen Corpโ€™s stock, indicating they expect its value to rise.

Above Average

Financial Health

Neogen Corp is achieving solid profits and revenue, showcasing a strong market position in its industry.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Discover More Opportunities

ABT

Abbott

Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.

A

AGILENT TECHNOLOGIES INC

Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.

ALGN

ALIGN TECHNOLOGY INC

Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.

Baskets Featuring NEOG

Next-Gen Proteins

Next-Gen Proteins

Looking to invest in the future of food? This carefully selected group of stocks represents companies solving our global protein challenges. From plant-based alternatives to agricultural innovation, these stocks have been thoughtfully chosen by our analysts for their potential in this growing market.

Published: June 17, 2025

Explore Basket

Why Youโ€™ll Want to Watch This Stock

๐Ÿ“ˆ

Recurring Consumables Demand

A sizeable portion of sales are repeat consumables and reagents, which can provide revenue durability โ€” though volumes may vary with industry spending.

๐ŸŒ

Regulation Supports Need

Tighter foodโ€‘safety rules and globalisation of supply chains can increase demand for testing and traceability, yet regulatory shifts can also change buyer behaviour.

โšก

Product & Acquisition Strategy

Neogen grows through new diagnostics and selective acquisitions that expand capabilities and distribution, but integration and margin effects warrant attention.

Why invest with Nemo?

Nemo Logo Fade
๐Ÿ†“

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

๐Ÿ”’

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

๐Ÿ’ฐ

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions